Akihiko MizorokiSenior Principal Scientist at Chugai Pharmabody ResearchSpeaker
Profile
Akihiko Mizoroki is a Senior Principal Scientist in Chugai Pharmabody Research(CPR) that is located in Singapore. At CPR, he is responsible for development of the novel technology for cell selective agonists. Before moving to CPR, he spent 12 years at Chugai Pharmaceutical Company and worked as a leader for several drug discovery projects including the antibody against HLA-DQ2.5 and gluten peptide complexes.
Agenda Sessions
A Novel Antibody Targeting the HLA-DQ2.5/Gluten Peptide Complex with Broad Cross-reactivity and Selectivity
, 5:15pmView Session